AG˹ٷ

STOCK TITAN

[Form 4] The Charles Schwab Corporation Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Carolyn Schwab-Pomerantz, a director of The Charles Schwab Corporation (SCHW), reported multiple sales of common stock executed on 08/07/2025 under a Rule 10b5-1 trading plan adopted August 14, 2024. The Form 4 shows sales of 14,000 and 400 shares held indirectly by a trust at weighted-average prices of $96.6799 and $97.22, and sales of 9,400 and 200 shares held indirectly by a spouse-as-trustee at weighted-average prices of $96.6818 and $97.205. The filings list resulting indirect beneficial holdings in the ranges of 1,477,598.6599 and 460,114�460,314 shares depending on account designation. The explanatory note discloses the execution price ranges and offers to provide full trade details on request.

Carolyn Schwab-Pomerantz, membro del consiglio di amministrazione di The Charles Schwab Corporation (SCHW), ha segnalato più vendite di azioni ordinarie eseguite il 08/07/2025 nell'ambito di un piano di negoziazione ai sensi della Regola 10b5-1 adottato il 14 agosto 2024. Il Modulo 4 indica vendite di 14.000 e 400 azioni detenute indirettamente da un trust a prezzi medi ponderati di $96.6799 e $97.22, e vendite di 9.400 e 200 azioni detenute indirettamente da un coniuge in qualità di trustee a prezzi medi ponderati di $96.6818 e $97.205. Le comunicazioni segnalano partecipazioni beneficiarie indirette risultanti negli intervalli di 1,477,598.6599 e 460,114�460,314 azioni a seconda della designazione del conto. Una nota esplicativa riporta gli intervalli di prezzo di esecuzione e offre i dettagli completi delle operazioni su richiesta.

Carolyn Schwab-Pomerantz, directora de The Charles Schwab Corporation (SCHW), informó varias ventas de acciones ordinarias ejecutadas el 08/07/2025 bajo un plan de negociación conforme a la Regla 10b5-1 adoptado el 14 de agosto de 2024. El Formulario 4 muestra ventas de 14.000 y 400 acciones mantenidas indirectamente por un fideicomiso a precios promedio ponderados de $96.6799 y $97.22, y ventas de 9.400 y 200 acciones mantenidas indirectamente por un cónyuge como fiduciario a precios promedio ponderados de $96.6818 y $97.205. Los registros indican participaciones beneficiarias indirectas resultantes en los rangos de 1,477,598.6599 y 460,114�460,314 acciones según la designación de la cuenta. Una nota explicativa detalla los rangos de precios de ejecución y ofrece proporcionar los detalles completos de las operaciones a solicitud.

The Charles Schwab Corporation(SCHW)� 이사 Carolyn Schwab-Pomerantz가 2024� 8� 14� 채택� Rule 10b5-1 거래계획� 따라 2025� 08/07일에 여러 건의 보통� 매도 사실� 신고했습니다. Form 4에는 신탁� 간접 보유� 14,000� � 400주의 매도가중평균가격이 각각 $96.6799 � $97.22�, 배우자가 수탁�(trustee)로서 간접 보유� 9,400� � 200주의 매도가중평균가격이 각각 $96.6818 � $97.205� 기재되어 있습니다. 제출서류� 계좌 지정에 따라 결과적인 간접� 실소� 지분이 1,477,598.6599� � 460,114�460,314� 범위� 있다� 명시합니�. 설명 노트에는 실행 가� 범위가 공개되어 있으�, 요청 � 거래 상세 내역� 제공하겠다고 밝혔습니�.

Carolyn Schwab-Pomerantz, administratrice de The Charles Schwab Corporation (SCHW), a déclaré plusieurs ventes d'actions ordinaires exécutées le 08/07/2025 dans le cadre d'un plan de négociation conforme à la règle 10b5-1 adopté le 14 août 2024. Le formulaire 4 indique des ventes de 14 000 et 400 actions détenues indirectement par un trust à des prix moyens pondérés de 96,6799 $ et 97,22 $, et des ventes de 9 400 et 200 actions détenues indirectement par un conjoint en tant que trustee à des prix moyens pondérés de 96,6818 $ et 97,205 $. Les dépôts signalent des participations bénéficiaires indirectes résultantes comprises dans les plages de 1,477,598.6599 et 460,114�460,314 actions selon la désignation du compte. Une note explicative précise les fourchettes de prix d'exécution et propose de fournir les détails complets des opérations sur demande.

Carolyn Schwab-Pomerantz, Direktorin von The Charles Schwab Corporation (SCHW), meldete mehrere Verkäufe von Stammaktien, die am 08/07/2025 im Rahmen eines gemäß Rule 10b5-1 eingerichteten Handelsplans ausgeführt wurden (Plan angenommen am 14. August 2024). Das Formular 4 weist Verkäufe von 14.000 und 400 Aktien aus, die indirekt von einem Trust gehalten werden, zu gewichteten Durchschnittspreisen von $96.6799 bzw. $97.22, sowie Verkäufe von 9.400 und 200 Aktien, die indirekt von einem Ehepartner als Trustee gehalten werden, zu gewichteten Durchschnittspreisen von $96.6818 bzw. $97.205. Die Einreichungen geben die daraus resultierenden indirekten wirtschaftlichen Beteiligungen in den Bereichen 1,477,598.6599 und 460,114�460,314 Aktien je nach Kontobezeichnung an. Eine erläuternde Anmerkung nennt die Ausführungspreisbereiche und bietet an, auf Anfrage vollständige Handelsdetails zu liefern.

Positive
  • Transactions executed pursuant to a Rule 10b5-1 trading plan, indicating pre-established trading instructions.
  • Reporting person retains substantial indirect holdings (reported as ~1,477,598.6599 and 460,114�460,314 shares across accounts).
Negative
  • At least 24,000 shares were disposed on 08/07/2025 (aggregate of four dated sale lines: 14,000; 400; 9,400; 200).
  • Some table lines lack explicit contextual details (e.g., a line showing a '9,624 D' disposition and a '2,798 I by LLC') which reduces immediate clarity of total dispositions and account mapping.

Insights

TL;DR: Multiple systematic insider sales under a pre-established 10b5-1 plan; reporting person retains substantial indirect holdings.

The Form 4 documents at least four sales on 08/07/2025 totaling 24,000 shares (14,400 from trust-designated lines and 9,600 from spouse-as-trustee lines when summed), executed at weighted-average prices in the mid-$96�$97 range. The reporter continues to hold large indirect positions (reported as ~1.48 million and ~460k shares across accounts). From a market-impact perspective this is a clear disclosure of routine plan-driven dispositions rather than an event indicating loss of control or reduction to single-digit ownership stakes.

TL;DR: Disclosure follows a documented Rule 10b5-1 plan and includes price ranges and an undertaking to provide trade details; compliance appears observed.

The filing explicitly states the trades were effected pursuant to a Rule 10b5-1 plan adopted on August 14, 2024, and provides weighted-average prices plus traded price ranges. The reporting person also affirms availability of full execution details upon request. These elements strengthen procedural transparency, though portions of the table (additional lines showing a 9,624 disposition and a 2,798 indirect interest by LLC) are presented without full contextual labeling, which could complicate immediate interpretation.

Carolyn Schwab-Pomerantz, membro del consiglio di amministrazione di The Charles Schwab Corporation (SCHW), ha segnalato più vendite di azioni ordinarie eseguite il 08/07/2025 nell'ambito di un piano di negoziazione ai sensi della Regola 10b5-1 adottato il 14 agosto 2024. Il Modulo 4 indica vendite di 14.000 e 400 azioni detenute indirettamente da un trust a prezzi medi ponderati di $96.6799 e $97.22, e vendite di 9.400 e 200 azioni detenute indirettamente da un coniuge in qualità di trustee a prezzi medi ponderati di $96.6818 e $97.205. Le comunicazioni segnalano partecipazioni beneficiarie indirette risultanti negli intervalli di 1,477,598.6599 e 460,114�460,314 azioni a seconda della designazione del conto. Una nota esplicativa riporta gli intervalli di prezzo di esecuzione e offre i dettagli completi delle operazioni su richiesta.

Carolyn Schwab-Pomerantz, directora de The Charles Schwab Corporation (SCHW), informó varias ventas de acciones ordinarias ejecutadas el 08/07/2025 bajo un plan de negociación conforme a la Regla 10b5-1 adoptado el 14 de agosto de 2024. El Formulario 4 muestra ventas de 14.000 y 400 acciones mantenidas indirectamente por un fideicomiso a precios promedio ponderados de $96.6799 y $97.22, y ventas de 9.400 y 200 acciones mantenidas indirectamente por un cónyuge como fiduciario a precios promedio ponderados de $96.6818 y $97.205. Los registros indican participaciones beneficiarias indirectas resultantes en los rangos de 1,477,598.6599 y 460,114�460,314 acciones según la designación de la cuenta. Una nota explicativa detalla los rangos de precios de ejecución y ofrece proporcionar los detalles completos de las operaciones a solicitud.

The Charles Schwab Corporation(SCHW)� 이사 Carolyn Schwab-Pomerantz가 2024� 8� 14� 채택� Rule 10b5-1 거래계획� 따라 2025� 08/07일에 여러 건의 보통� 매도 사실� 신고했습니다. Form 4에는 신탁� 간접 보유� 14,000� � 400주의 매도가중평균가격이 각각 $96.6799 � $97.22�, 배우자가 수탁�(trustee)로서 간접 보유� 9,400� � 200주의 매도가중평균가격이 각각 $96.6818 � $97.205� 기재되어 있습니다. 제출서류� 계좌 지정에 따라 결과적인 간접� 실소� 지분이 1,477,598.6599� � 460,114�460,314� 범위� 있다� 명시합니�. 설명 노트에는 실행 가� 범위가 공개되어 있으�, 요청 � 거래 상세 내역� 제공하겠다고 밝혔습니�.

Carolyn Schwab-Pomerantz, administratrice de The Charles Schwab Corporation (SCHW), a déclaré plusieurs ventes d'actions ordinaires exécutées le 08/07/2025 dans le cadre d'un plan de négociation conforme à la règle 10b5-1 adopté le 14 août 2024. Le formulaire 4 indique des ventes de 14 000 et 400 actions détenues indirectement par un trust à des prix moyens pondérés de 96,6799 $ et 97,22 $, et des ventes de 9 400 et 200 actions détenues indirectement par un conjoint en tant que trustee à des prix moyens pondérés de 96,6818 $ et 97,205 $. Les dépôts signalent des participations bénéficiaires indirectes résultantes comprises dans les plages de 1,477,598.6599 et 460,114�460,314 actions selon la désignation du compte. Une note explicative précise les fourchettes de prix d'exécution et propose de fournir les détails complets des opérations sur demande.

Carolyn Schwab-Pomerantz, Direktorin von The Charles Schwab Corporation (SCHW), meldete mehrere Verkäufe von Stammaktien, die am 08/07/2025 im Rahmen eines gemäß Rule 10b5-1 eingerichteten Handelsplans ausgeführt wurden (Plan angenommen am 14. August 2024). Das Formular 4 weist Verkäufe von 14.000 und 400 Aktien aus, die indirekt von einem Trust gehalten werden, zu gewichteten Durchschnittspreisen von $96.6799 bzw. $97.22, sowie Verkäufe von 9.400 und 200 Aktien, die indirekt von einem Ehepartner als Trustee gehalten werden, zu gewichteten Durchschnittspreisen von $96.6818 bzw. $97.205. Die Einreichungen geben die daraus resultierenden indirekten wirtschaftlichen Beteiligungen in den Bereichen 1,477,598.6599 und 460,114�460,314 Aktien je nach Kontobezeichnung an. Eine erläuternde Anmerkung nennt die Ausführungspreisbereiche und bietet an, auf Anfrage vollständige Handelsdetails zu liefern.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schwab-Pomerantz Carolyn

(Last) (First) (Middle)
3000 SCHWAB WAY

(Street)
WESTLAKE TX 76262

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SCHWAB CHARLES CORP [ SCHW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/07/2025 S(1) 14,000 D $96.6799(2) 1,477,598.6599 I by Trust
Common Stock 08/07/2025 S(1) 400 D $97.22(3) 1,477,198.6599 I by Trust
Common Stock 08/07/2025 S(1) 9,400 D $96.6818(2) 460,314 I by Spouse as Trustee
Common Stock 08/07/2025 S(1) 200 D $97.205 460,114 I by Spouse as Trustee
Common Stock 9,624 D
Common Stock 2,798 I by LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.
2. This transaction was executed in multiple trades at prices ranging from $96.19 to $97.175. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. This transaction was executed in multiple trades at prices ranging from $97.20 to $97.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks:
/s/ P. Blake Allen, Attorney-in-fact 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed this Form 4 for SCHW?

The Form 4 was filed by Carolyn Schwab-Pomerantz, who is identified in the form as a director of The Charles Schwab Corporation (SCHW).

What transactions are reported on this SCHW Form 4?

The filing reports sales executed on 08/07/2025: 14,000 and 400 shares held indirectly by a trust, and 9,400 and 200 shares held indirectly by a spouse-as-trustee, all marked as sales.

Were the trades executed under a 10b5-1 plan for SCHW?

Yes. The Form 4 states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2024.

What prices were reported for the SCHW share sales?

Weighted-average prices reported include $96.6799, $97.22, $96.6818, and $97.205; explanatory notes also list traded price ranges within the mid-$96�$97 area.

How many shares does the reporting person beneficially own after the transactions?

The form shows indirect beneficial holdings after the reported transactions of approximately 1,477,598.6599 shares (trust-designated lines) and 460,114�460,314 shares (spouse-as-trustee lines), depending on account designation.

Are any derivative securities reported on this Form 4 for SCHW?

No. Table II for derivative securities contains no entries, so no derivative securities were reported in this filing.
Schwab (CHARLES) Corp. (The)

NYSE:SCHW

SCHW Rankings

SCHW Latest News

SCHW Latest SEC Filings

SCHW Stock Data

173.52B
1.70B
6.06%
84.93%
1.05%
Capital Markets
Security Brokers, Dealers & Flotation Companies
United States
WESTLAKE